Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

943 recalls · Class II, newest first

Class II · Moderate risk

Moxifloxacin

Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL

Terminated Labeling / mix-up Denver Solutions, LLC DBA Leiters Health NDC 71449-096-42 D-0288-2022
Class II · Moderate risk

The Natural Dentist Healthy Balance Peppermint Sage

Labeling; Label mix-up and Wrong Bar Code; back label incorrectly states active ingredient as Menthol with UPC 7 14132 00071 4 instead of Peppermint Oil and Sage Oil with UPC 7 14132 00073 8

Ongoing Labeling / mix-up Revive Personal Products Company D-0364-2022
Class II · Moderate risk

Rocuronium Bromide Injection 50mg/5 mL

Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, "WARNING: PARALYZING AGENT"

Terminated Labeling / mix-up Piramal Critical Care, Inc. NDC 66794-0228-41 D-0019-2022
Class II · Moderate risk

Kroger 70% Isopropyl Alcohol First Aid Antiseptic 32 FL OZ

Labeling: Label Mix-Up.The recall has been initiated after receiving one complaint about incorrect labeling.The primary label on the front and back label on some of the bottles have 70% Isopropyl Alcohol affixed to the containers. However, the product inside the bottle is Hydrogen Peroxide, Topical Solution USP with active ingredient Hydrogen Peroxide (stabilized) 3%, 32 FL Ounces

Terminated Labeling / mix-up Vi-Jon, Inc. NDC 30142-810-45 D-0799-2021
Class II · Moderate risk

Trulicity (dulaglutide)

Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.

Terminated Labeling / mix-up Eli Lilly & Company NDC 0002-1433-80 D-0773-2021
Class II · Moderate risk

Micafungin for Injection

Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does not include all required sections approved for this product. This includes aspects of Adverse Reactions, Drug Interactions and Use in Specific Populations.

Terminated Labeling / mix-up Xellia Pharmaceuticals USA, LLC NDC 70594-037-01 D-0757-2021
Class II · Moderate risk

Micafungin for Injection

Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does not include all required sections approved for this product. This includes aspects of Adverse Reactions, Drug Interactions and Use in Specific Populations.

Terminated Labeling / mix-up Xellia Pharmaceuticals USA, LLC NDC 70594-036-01 D-0756-2021
Class II · Moderate risk

Venlafaxine Tablets

Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg

Terminated Labeling / mix-up Sun Pharmaceutical Industries INC NDC 16714-657-01 D-0703-2021
Class II · Moderate risk

ChloraPrep With Tint 2% w/v chlorhexidine gluconate

CGMP Deviations: Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

Terminated Labeling / mix-up CareFusion 213, LLC D-0350-2021
Class II · Moderate risk

ChloraPrep One-Step 2% w/v chlorhexidine gluconate

CGMP Deviations: Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

Terminated Labeling / mix-up CareFusion 213, LLC D-0349-2021
Class II · Moderate risk

Spironolactone Tablets

Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets.

Ongoing Labeling / mix-up Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals NDC 63629-1067-01 D-0304-2021
Class II · Moderate risk

Sulfur Ointment 10%

Labeling: Label Mix-Up. THe English label with Drug Facts panel for Camphor was incorrectly placed on product.

Terminated Labeling / mix-up DLC Laboratories, Inc D-0257-2021
Class II · Moderate risk

N-A-C

Mislabeling of SUS (N-A-C Sustain 600 mg 100 tab) with N-A-C N-Acetyl-L-Cysteine 500 mg, 100 cap.

Terminated Labeling / mix-up Jarrow Formulas Inc D-0302-2021
Class II · Moderate risk

Killz Germz Hand Sanitizer

Sub-Potent Drug; Killz GERMz was recalled due to sub-potent results. Testing revealed ethanol levels as low as 62% while labelled claim is 70%.

Ongoing Labeling / mix-up Genesis Partnership Company SA NDC 74625-003-05 D-0041-2021
Class II · Moderate risk

Killz Germz Hand Sanitizer

Sub-Potent Drug; Killz GERMz was recalled due to sub-potent results. Testing revealed ethanol levels as low as 62% while labelled claim is 70%.

Ongoing Labeling / mix-up Genesis Partnership Company SA NDC 74625-003-04 D-0040-2021

Recalls by year